E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers S > Headlines for Stem Cell Sciences Ltd. > News item
Published on 6/24/2005 in the Prospect News Biotech Daily.

Stem Cell Sciences to seek listing on Alternative Investment Market, raise £10 million

By Jennifer Chiou

New York, June 24 - BioTech Capital announced Stem Cell Sciences Ltd. has notified the London Stock Exchange it intends to obtain a listing on the Alternative Investment Market.

Collins Stewart plc will be advisor and broker in Stem Cell's effort to raise up to £10 million.

Timing and pricing on the deal are yet to be determined.

Sydney, Australia-based BioTech Capital, a private equity fund focused on life science, has a 15.7% stake in Stem Cell, which is based in Edinburgh, Scotland.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.